The price of capapasetinib is affected by dosage, region, and purchase channel. Currently, there is no publicly announced uniform price in China. In overseas markets, the cost of a single course of treatment is approximately tens of thousands to hundreds of thousands of RMB (the exact price depends on the actual purchase). This drug is a targeted therapy primarily used for specific cancer patients and must be used strictly according to the doctor's prescription.
Main Factors Affecting Price
Dosage and Treatment Course
The price of the drug is directly related to the single dose and the overall duration of treatment. Different indications or stages of the disease may lead to differences in the medication regimen, thus affecting the total cost.
Regional Pricing Policies
Prices in overseas markets (such as the United States and Europe) are generally higher, and some regions may reimburse part of the cost through medical insurance. If it is not available in China, it must be purchased through special channels, and the price may fluctuate significantly.
Hospital and Pharmacy Channels
Public hospitals or designated pharmacies may offer more stable prices, while private institutions or cross-border purchasing agents may incur additional service fees or transportation costs.
Medication Precautions
Prescription Drug Information: Capapasetinib requires a doctor's prescription. Patients should not adjust the dosage or discontinue use on their own. Regular follow-up examinations are necessary to monitor efficacy and side effects.
Medical Guidance: It is recommended to obtain the medication through a qualified medical institution and discuss the medication plan, cost, and possible alternative treatments with your attending physician.
For the latest price or to apply for medication, please contact the pharmacy of an oncology hospital or a compliant overseas drug purchasing agency for verification.
